CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK monocle study
Authors
D Bowen
C Cargo
+14Â more
DJ Culligan
M Dennis
RJ Dillon
MW Drummond
RK Hills
M Hodges
S Knapper
C Pocock
J Taylor
L Upton
P Vyas
D Wiseman
M Wright
J Zabkiewicz
Publication date
1 January 2018
Publisher
'American Society of Hematology'
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Supporting member
Oxford University Research Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:ora.ox.ac.uk:uuid:e35941a5...
Last time updated on 25/11/2020